“The Chinese drug industry is on the verge of getting the green light to manufacture the Japanese encephalitis vaccine for the developing world, an event that will signal the emergence of a major new player in global vaccines,” BMJ reports. Seth Berkley, chief executive of the GAVI Alliance, “said that by the beginning of next year Chinese drug firms will be ready for World Health Organization representatives to carry out pre-qualification inspections of production of the vaccine,” the journal writes, adding, “Once those inspections are carried out, United Nations agencies and other non-governmental organizations will be able to purchase the vaccine for countries that do not have their own regulatory systems.”
Programs, Funding & Financing
In this post in the Center for Global Development’s (CGD) “Global Health Policy” blog, Victoria Fan, a CGD research fellow, and Rachel Silverman, a research assistant for the global health team at the center, examine the future of UNITAID. “Perhaps due to its relative obscurity and late entry to a crowded global health field, UNITAID has proactively worked to differentiate itself through a focus on commodities, market shaping, novel funding sources, and innovation,” but, “as UNITAID celebrates its sixth birthday …, it stands at a potential crossroads,” they write. Fan and Silverman note that a five-year evaluation report on the future of UNITAID, commissioned by its Executive Board, is forthcoming, and they highlight a paper (.pdf) in which they “outline some contradictions and limitations of UNITAID’s current approach.” They write, “We hope that the imminent evaluation provides the impetus for UNITAID to turn inward and do something truly innovative: buck institutional inertia, change course as necessary, and reinvent itself as the solution to 2012’s biggest global health challenges” (9/17).
Blog Examines U.S. Presidential Candidates' Foreign Policy, Science Stances With Respect To Global Health
“If nothing else, this presidential election season has brought the good news that both major party candidates have taken stances against preventable death and disease,” the Center for Global Health Policy’s “Science Speaks” blog writes, noting the blog “looked at two recently published examinations of the candidates’ foreign policy and science stances, candidates’ party platforms and other posted materials for clues to where the candidates diverge on major global health issues.” According to the blog, an analysis from Devex “looks at the candidates’ words, supporters’ statements and party platforms on an array of foreign spending issues, including global health,” and an article in Nature “invited the candidates to share thoughts on matters scientific, including research investment, vaccinations, pandemic preparedness, and the role of science in public policy” (Barton, 9/17).
David Winder, chief executive of WaterAid USA, highlights the findings of the recently released UNICEF report on child mortality in this Huffington Post “Impact” blog post, saying the decrease in annual number of child deaths “is great news, but is tempered by sobering statistics, especially for children in sub-Saharan Africa,” who continue to face high rates of mortality. “However all is not lost and much can be done to ameliorate the situation. Improving access to safe drinking water, sanitation and hygiene is a key step in preventing many of these needless deaths,” he writes, adding, “Known collectively as WASH, these three basic services are important factors in preventing pneumonia and diarrhea, the leading causes of mortality among children between one month and five years of age.”
OMB Report On Budgetary Impact Of Sequestration Estimates Global Health Funding Would Decrease By 8.2%
The White House Office of Management and Budget (OMB) on Friday released a report (.pdf) describing the budgetary impacts of sequestration “mandated by the 2011 Budget Control Act,” which would require an annual reduction in government spending of $109 billion per year for nine years, National Journal reports. “Sequestration will go into effect starting Jan. 2 unless Congress can reach a deficit-reduction deal to head it off,” the news service notes (O’Donnell et al., 9/14). “According to the report, global health funding through USAID and State Department, which comprises the majority of U.S. global health funding, would decrease by $670 million, or 8.2 percent, from the FY 2012 level of $8,168 million,” according to the Kaiser Family Foundation’s “Policy Tracker” (9/14).
According to a press release from the Global Fund to Fight AIDS, Tuberculosis and Malaria, the fund’s Board on Friday “voted to adopt a new approach to funding grants that will enable the organization to invest the world’s money more strategically and for greater impact.” The press release notes “the new funding model will change the way implementers apply for financing, get approval of their proposals and then manage their grants,” and it describes the changes in more detail. “In its decision, the Board agreed that the new model should enhance participation by all stakeholders, including civil society and will support continued funding for the needs of most-at-risk populations, so that concentrated epidemics are taken into consideration,” the press release states, adding, “The Board also requested a regular evaluation of the new funding model, and asked the Board’s Strategy Investment and Impact Committee to continue working out the details of the funding model so that implementation can begin in 2013” (9/14).
“The non-communicable disease [NCD] community always talks about the importance of prevention; many consider it the Holy Grail in the fight against NCDs. Why was it so hard to also accept treatment as part of the solution?” Princess Dina Mired, director general of the King Hussein Cancer Foundation in Amman, Jordan, asks in the Huffington Post “Impact” blog, noting only one target of the 2011 U.N. High-Level Meeting on NCDs “deals with treatment, the target on ‘essential medicines and basic technologies for treatment.'” She continues, “Treatment and prevention are heavily interrelated. The success of one is directly related to the other.” She adds, “A person in the developing world will not buy in to the importance of prevention if there is no treatment option available should that person get the disease.”
World Bank, Bangladeshi Government Sign Multi-Donor Trust Fund Agreement For Country's Health Sector
“On Wednesday, the World Bank and the Bangladeshi government signed a Multi-Donor Trust Fund Grant Agreement” under which “$280 million coming from the United States, Australia, the United Kingdom, and Sweden will go to the Bangladesh Health Sector Development Program, which aims to improve the health status of people in Bangladesh, particularly women, children and the marginalized,” the Devex “Development Newswire” reports. “The government will finance 75 percent of the program,” and “[t]he World Bank will also provide a $359 million credit through its anti-poverty arm, the International Development Association,” the news service writes (Ravelo, 9/13). “The program will focus on improving emergency obstetric and newborn care services and the nutritional status of expectant mothers and their children” and “will also strengthen health sector planning and resource management, human resources development, management of pharmaceuticals, health information systems and maintenance of health care facilities,” a World Bank press release states (9/12).
The board of the Global Fund to Fight AIDS, Tuberculosis and Malaria began a two-day meeting in Geneva on Thursday, “with one topic high on the agenda: a new funding model,” Devex’s “Development Newswire” reports. “The board will tackle aspects of a new funding model, which, according to Global Fund Director of Communications Seth Faison, ‘will change the way the Global Fund has made grants for 10 years,'” the news service writes, adding that the model, according to the International HIV/AIDS Alliance, “will see the Global Fund dropping its ’round’ grant-making process and replacing it with a ‘more flexible’ system.” In addition, “an ‘iterative dialogue process’ is also reportedly being explored,” Devex reports. “The proposed reforms seem good for the fund and its beneficiaries … [b]ut some have expressed their concerns on the funding model under consideration, specifically on the ‘historical disease application’ approach,” the news service writes (Ravelo, 9/13). According to an article on the Stop TB Partnership website, the new approach “would cap the proportion of funding available to tuberculosis (TB) projects at 16 percent,” and the proposal, “which is based on the proportion of grants awarded to TB in the past, met with strong objections from the community of people working on TB worldwide” (9/13).
Humanitarian Situation Better, Still Tenuous, In Zimbabwe As E.U. Scales Down Assistance, IRIN Reports
Though the number of people in Zimbabwe in need of food aid has dropped from seven million in 2002-2003 to one million currently, the number could still rise by 600,000 in 2013, IRIN reports in an analysis of the humanitarian and political situation in the country. “Still, two of the country’s biggest donors, the European Union and the U.S., and their implementing partner, the U.N., say Zimbabwe is on its way to recovery and development,” the news service writes, noting “[t]he E.U. has announced that it is scaling down its humanitarian assistance.” IRIN states, “The E.U. has moved from funding only emergency food aid to funding nutrition, health, water and sanitation, and protection programs. [U.N. Financial Tracking Service (FTS)] data show that the health and education sectors are better funded than last year, but agriculture programs are worse off.”